Document is current
Any future updates will be listed below
-
Authors
Boussaad, Ibrahim
Cruciani, Gérald
Bolognin, Silvia
Antony, Paul
Dording, Claire M.
Kwon, Yong-Jun
Heutink, Peter
Fava, Eugenio
Schwamborn, Jens C.
Krüger, Rejko
-
Funding
Funding for this research was provided by:
Fonds National de la Recherche Luxembourg (FNR/P13/6682797, INTER/JPND/15/11092422)
EU Joint Programme – Neurodegenerative Disease Research (INTER/JPND/15/11092422)
- License Information
-
More Information
Article History
Received: 2 April 2020
Accepted: 24 December 2020
First Online: 14 January 2021
Competing interests
: S.B. and J.C.S are co-founders and shareholders of the biotech company OrganoTherapeutics. The other authors declare to have no competing interests.
